Related Experiment Video
Updated: Feb 14, 2026

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model
Published on: April 16, 2014
ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent
Dong-Yu Liang1,2, Wei Huang3, Qing Chang2
1Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Evidence has shown that most hepatocellular carcinoma (HCC) cells are resistant to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. However, the molecular mechanisms underlying TRAIL-mediated apoptosis resistance are not well understood. In this study, we reported that downregulation of Decoy receptor 3 (DcR3) expression by lentiviral vectors carrying shRNA against DcR3 (LV-ShDcR3, shDcR3) in Huh7 both greatly enhanced TRAIL-mediated apoptosis and reduced cell proliferation capability. In addition, silencing DcR3 resulted in upregulation of the cell apoptotic regulators including Bid, caspase-3, and caspase-8. Caspase inhibitors inhibited shDcR3-mediated cell death, which indicated that downregulation of DcR3 expression in Huh7 cells increased TRAIL-induced caspase-dependent apoptotic cell death. Furthermore, although the knockdown of DcR3 altered the expression of some Bcl-2- and IAP-family proteins, this change was inhibited by pretreatment with a pancaspase inhibitor, which indicated the cytotoxic effect of shDcR3 was not due to the expression of these proteins. In contrast, shDcR3 significantly inhibited TRAIL-induced transcription factor nuclear κB (NF-κB) activation through the IκB kinase (IKK) pathway, as well as inhibited TRAIL-induced increases in FLICE-inhibitory protein long form (cFLIPL) expression at the transcriptional level. Silencing cFLIPL expression mimicked the cytotoxic effect of shDcR3 on TRAIL-mediated cell apoptosis. Moreover, overexpression of cFLIPL effectively prevented the increase in cell apoptosis in Huh7 cells co-treated with TRAIL and shDcR3. Taken together, our findings indicated that silencing DcR3 sensitizes TRAIL-mediated apoptosis in HCC cells by inhibiting NF-κB.
Insights
Hepatocellular carcinoma (HCC) cells resist tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) therapy. Silencing Decoy receptor 3 (DcR3) enhances TRAIL-induced apoptosis in HCC cells by inhibiting the NF-κB pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Hepatocellular carcinoma (HCC) exhibits resistance to apoptosis-inducing therapies like tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).
- The molecular mechanisms driving this TRAIL resistance in HCC remain incompletely understood.
- Decoy receptor 3 (DcR3) is implicated in cancer progression and immune evasion.
Purpose of the Study:
- To investigate the role of Decoy receptor 3 (DcR3) in TRAIL-mediated apoptosis resistance in HCC cells.
- To elucidate the molecular pathways through which DcR3 influences TRAIL sensitivity.
- To evaluate the therapeutic potential of targeting DcR3 to enhance TRAIL-induced apoptosis in HCC.
Main Methods:
- Utilized lentiviral vectors with short hairpin RNA (shRNA) to downregulate DcR3 expression in Huh7 HCC cells.
- Assessed apoptosis induction using TRAIL treatment in DcR3-silenced and control cells.
- Analyzed the expression of key apoptotic regulators, transcription factors (NF-κB), and related proteins (cFLIPL) using molecular assays.
- Investigated the involvement of caspase-dependent pathways and the IκB kinase (IKK) pathway.
Main Results:
- Downregulation of DcR3 significantly enhanced TRAIL-mediated apoptosis and reduced proliferation in Huh7 cells.
- Silencing DcR3 upregulated pro-apoptotic proteins (Bid, caspase-3, caspase-8) and increased caspase-dependent cell death.
- DcR3 knockdown inhibited TRAIL-induced nuclear factor κB (NF-κB) activation via the IκB kinase (IKK) pathway and suppressed cFLIPL expression.
- cFLIPL silencing mimicked the cytotoxic effects of DcR3 knockdown, while its overexpression blocked TRAIL/shDcR3-induced apoptosis.
Conclusions:
- Decoy receptor 3 (DcR3) plays a critical role in conferring resistance to TRAIL-induced apoptosis in hepatocellular carcinoma (HCC).
- Silencing DcR3 sensitizes HCC cells to TRAIL by inhibiting the NF-κB signaling pathway and downregulating cFLIPL.
- Targeting DcR3 represents a promising strategy to overcome TRAIL resistance in HCC treatment.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Frequency-dependent Selection
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Temperature Dependence on Reaction Rate
Atoms, molecules, or ions must collide before they can react with each other. Atoms must be close together to form chemical bonds. This premise is the basis for a theory that explains many observations regarding chemical kinetics, including factors affecting reaction rates.
The collision theory is based on the postulates that (i) the reaction rate is proportional to the rate of reactant collisions, (ii) the reacting species collide in an orientation allowing contact between...
Drug Dependence
Independent and Dependent Sources
Independent voltage or current sources supply a fixed amount of voltage or current, respectively, which is unaffected by other elements within the circuit. These are represented using specific symbols. Independent voltage sources are symbolized with polarities (+ and -), indicating the direction of the...

